These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


267 related items for PubMed ID: 11510285

  • 1. The relationship between dialysate protein loss and membrane transport status in peritoneal dialysis patients.
    Cooper S, Iliescu EA, Morton AR.
    Adv Perit Dial; 2001; 17():244-7. PubMed ID: 11510285
    [Abstract] [Full Text] [Related]

  • 2. Adequacy and nutrition in pediatric peritoneal dialysis.
    Cano FJ, Marín VS, Azocar MA, Delucchi MA, Rodriguez EE, Diaz ED, Villegas RC.
    Adv Perit Dial; 2003; 19():273-8. PubMed ID: 14763078
    [Abstract] [Full Text] [Related]

  • 3. Inflammation, peritoneal transport, and response to erythropoietin in peritoneal dialysis patients.
    Pilkey RM, Morton AR, Iliescu EA.
    Adv Perit Dial; 2001; 17():153-7. PubMed ID: 11510266
    [Abstract] [Full Text] [Related]

  • 4. Relationship of peritoneal transport rate and dialysis adequacy with inflammation in peritoneal dialysis patients.
    Fein PA, Fazil I, Rafiq MA, Schloth T, Matza B, Chattopadhyay J, Avram MM.
    Adv Perit Dial; 2006; 22():2-6. PubMed ID: 16983929
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differences in peritoneal equilibration test results in patients aged above or below 60 years.
    Grzegorzewska AE, Leander M, Mariak I.
    Adv Perit Dial; 2002; 18():33-9. PubMed ID: 12402583
    [Abstract] [Full Text] [Related]

  • 8. Outcome for continuous ambulatory peritoneal dialysis patients is not predicted by peritoneal permeability characteristics.
    Passadakis PS, Thodis ED, Panagoutsos SA, Selisiou CA, Pitta EM, Vargemezis VA.
    Adv Perit Dial; 2000; 16():2-6. PubMed ID: 11045251
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of the dialysis adequacy and transport test in peritoneal dialysis.
    Seo JJ, Kim YL, Park SH, Kim CD, Kim JC, Jang MH, Choi HJ.
    Adv Perit Dial; 2005; 21():25-30. PubMed ID: 16686280
    [Abstract] [Full Text] [Related]

  • 10. Peritoneal protein losses in diabetic patients starting peritoneal dialysis: is there a relationship with diabetic vascular lesions?
    Coronel F, Cigarrán S, Herrero JA, Delgado J, Ramos F, Gomis A.
    Adv Perit Dial; 2009; 25():115-8. PubMed ID: 19886331
    [Abstract] [Full Text] [Related]

  • 11. Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solution.
    Cara M, Virga G, Mastrosimone S, Girotto A, Rossi V, D'Angelo A, Bonfante L.
    J Nephrol; 2005; 18(1):67-71. PubMed ID: 15772925
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of peritoneal transport properties at onset of peritoneal dialysis and longitudinal follow-up.
    Clerbaux G, Francart J, Wallemacq P, Robert A, Goffin E.
    Nephrol Dial Transplant; 2006 Apr; 21(4):1032-9. PubMed ID: 16364990
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Can the creatinine dialysate-to-plasma ratio from the peritoneal equilibration test be replaced by the sodium dialysate-to-plasma ratio and the sodium level in the dialysate?
    García R, Miguel A, Oviedo M, Martínez A, Esteve S, Pérez-Contreras J.
    Adv Perit Dial; 2000 Apr; 16():19-21. PubMed ID: 11045254
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S, Tutal E, Arat Z, Akçay A, Celik H, Ozdemir FN, Haberal M.
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [Abstract] [Full Text] [Related]

  • 18. Transport of peritoneal membrane assessed before and after the start of peritoneal dialysis.
    La Milia V, Limardo M, Cavalli A, Crepaldi M, Locatelli F.
    Nephrol Dial Transplant; 2009 Sep; 24(9):2894-8. PubMed ID: 19349295
    [Abstract] [Full Text] [Related]

  • 19. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up.
    Zweers MM, Struijk DG, Smit W, Krediet RT.
    J Lab Clin Med; 2001 Feb; 137(2):125-32. PubMed ID: 11174469
    [Abstract] [Full Text] [Related]

  • 20. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nishina M, Endoh M, Suzuki D, Tanabe R, Endoh H, Hirahara I, Sakai H.
    Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.